NM283: Final Phase I data

In a dose-escalation, placebo-controlled, double-blind, U.S. Phase I

Read the full 84 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE